Critical congenital heart disease (CCHD) refers to severe heart defects that require intervention, such as surgery or catheter procedures, in the first year of life. CCHD accounts for about 25% of all congenital heart disease cases. Common types include those dependent on ductal flow, such as hypoplastic left heart syndrome, as well as defects affecting the right ventricle outflow tract like pulmonary atresia. Diagnosis is based on symptoms like cyanosis and screening involves pulse oximetry of the right hand and foot in newborns. Treatment options include pharmacological therapy with prostaglandin E1 to keep the ductus arteriosus open, as well as surgical or catheter-based procedures.